Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or the Conquer Cancer Foundation.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy

ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy


Date: Saturday, June 2, 2018

Time: 7:00 PM – 9:00 PM
Dinner and registration: 6:30 PM – 7:00 PM

Location:
Hilton Chicago
International Ballroom South (Second Level)
720 South Michigan Avenue
Chicago, IL 60605

What You'll Learn:

  • The benefit of immunotherapy in advances or metastatic cSCC
  • Recently reported date that will change clinical practice
  • Multidisciplinary approaches to improve outcomes for your patients
  • Application of new cSCC data presented in Chicago

Overview:

Current treatment response rates in patients with cutaneous squamous cell carcinoma (cSCC) are suboptimal, with a minority of patients experiencing complete or partial response with present pharmacologic treatment options. Moreover, surgeries to remove cSCC tumors can be disfiguring, and your elderly patients often are not candidates for chemotherapeutic agents because they cannot tolerate the toxicities. There is clearly an unmet clinical need for improved cytoreductive strategies that may mitigate deleterious surgical outcomes in these treatment settings for your patients.

In this program, you will hear expert faculty discussing advances in immunotherapies for the treatment of advanced or metastatic cSCC, including how to translate the most recent data sets to your clinical practice, and how you can improve your role in personalized, multidisciplinary, teambased patient management. You will also learn strategies for cementing best practices for the mitigation and proactive management of treatment-related adverse events In particular, experts will provide you clinical context concerning noteworthy evidence in cancer immunotherapy, their take on how this impacts care of your patients, and how to safely apply these novel approaches.

Program Chair:

Jason Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL

This activity is supported by educational grants from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

Please note that attendance is on a first-come, first-served basis. Please arrive early to ensure your spot!

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.

Click to see all our ASCO programs!







Become a Member

Forgot Password?
Filter By